Home       Market Dynamics     Macro Trends     Sector Trends     Company Insights     AI Investing     Strategies     Sign Up     Login         

Eli Lilly (LLY) Stock Price Prediction and News Highlight
Fri. Jan 30, 2026

One Week Return: -2.46%, One Month Return: -3.92%, Three Month Return: 22.87%

Sector: Pharmaceuticals

Eli Lilly is making significant strides in product and service development, particularly through its advancements in obesity and diabetes treatments. Notable investments in gene therapy and artificial intelligence reflect a robust commitment to innovative healthcare solutions. The company's focus on developing next-generation obesity drugs and enhancing domestic manufacturing capabilities further solidifies its position as a leader in pharmaceuticals. These initiatives aim to address critical health issues and improve patient outcomes.

The price action of Eli Lilly (LLY) is impacted by broad market risk appetite, sector price trend, company-specific performance and market structure. The trend sentiment at -0.6 is bearish. The market sentiment at 0.2 is modestly bullish. Trend sentiment measures the current trend of the stock price, and market sentiment reflects what market participants collectively think where the price will move next. There is no clear direction for LLY since trend sentiment and market sentiment are at the opposite directions. The positive sentiment force for sector is at 0.8, and the negative at -0.6 on 2026-01-30. The forces of Market Risk Appetite (-3.2), and Stock Price Trend (-0.6) will drive down the price. The forces of Price Level Sentiment (0), Sector Price Trend (0.5), Valuation Sentiment (0.6), Option Sentiment (0.8), and Sentiment towards Fundamentals (3.3) will drive up the price.

The sentiment for Sector Price Trend is calculated based on the price trend of related sector ETF. The sentiment for Option Speculation is calculated from put/call ratio. The Risk Appetite is calculated from Bitcoin price trend. Price Level sentiment is positive when oversold, and negative when overbought. Valuation Sentiment, and Sentimentals towards Fundamentals are extracted from headlines and market commentary. All sentiment scores are normalized on a -10 - +10 scale. The price level reaches 100 at Bollinger upper band, and zero at lower band.

Earning Release: 2026-02-04 06:30, EPS: $20.37, P/E: 50.96

Sign up to reveice notifications on Market Movers
LLY
DateAttentionPriceStdDevPrice
Level
Change10 Day
Trend
Trend
Sentiment
Hourly
Trend
Sentiment
Hourly
StdDev
Market
Sentiment
ActionPFund.News
Sentiment
2026-01-301%(0.1%)      1037.99 2.24%    26    1.37%    0.06% -0.6    0.3    0.9%    0.2    Wait    50% 3.3    3.6   
2026-01-290%(0%)      1023.92 2.23%    8    0.01%    -0.47% -2    -0.2    1.1%    0.1    Short    55% 3.4    -1   
2026-01-280%(0%)      1023.79 2.09%    2    -1.46%    -0.5% -1.8    -0.2    2.1%    0.4    Short    70% 3.1    7   
2026-01-270%(0%)      1039.01 1.87%    13    -2.22%    -0.39% -0.7    -0.8    0.9%    0.6    Short    55% 2.7    -1   
2026-01-260%(0%)      1062.65 1.73%    41    -0.15%    -0.01% 0.4    -0.2    1%    0.5    Short    55% 2.5    -1   
2026-01-250%(0%)    0.4    -0.2    0.1          2.5    -1   
2026-01-240%(0%)    0.4    -0.2    0.1          2.5    -1   
2026-01-230%(0%)      1064.19 1.73%    42    -2.13%    -0.2% 0.4    -0.5    0.8%    0.5    Short    55% 3.2    -1   
2026-01-220%(0%)      1087.34 1.69%    73    0.82%    -0.2% 0.2    0.4    1.7%    0.5    Long    55% 2.8    -1   
2026-01-210%(0%)      1078.5 1.67%    62    3.54%    0.14% 0.1    0.7    1.5%    0.6    Long    55% 1.9    -1   
 
Wait is the preferred trading strategy with 50% chance of being right.

Wait action is recommended in three scenarios with either high uncertainty or high risk: 1. The trend sentiment and market sentiment are at the opposite directions. 2. Both trend sentiment and market sentiment are positive, but the price level is elevated. 3. Both trend sentiment and market sentiment are negative, but the price level is depressed. In an uptrend, as an investor, you may want to wait for the pullback to open long position. In a downtrend, the price will likely rebound after huge decline. As an investor, you may want to wait for the rebound to exit long position.

Market sentiment will accelerate the current trend when both trend sentiment and market sentiment are at the same direction. Market sentiment will generate volatility when it's at the opposite direction of the trend sentiment. News sentiment measures the daily emotion of the market. News sentiment may impact the daily price change while market sentiment is a more stable and consistent moving force.

2026-01-30 17:50:34 Eli Lilly's CEO expresses confidence in the company's competitive position regarding upcoming obesity drugs, which suggests a robust strategy to capture market share in a growing sector.
2026-01-30 17:50:34 The significant investment in constructing a new manufacturing facility highlights Eli Lilly's strategic move to expand its production capacity for obesity medications, indicating growth and confidence in market demand.
2026-01-30 17:50:34 Eli Lilly's focus on developing next-generation obesity drugs indicates a strong commitment to addressing obesity and related health issues, showcasing innovation in the pharmaceutical industry.
2026-01-30 17:02:36 The entry of new obesity treatments, including those from competitors, poses challenges and opportunities for Eli Lilly in the market.
2026-01-30 17:02:36 Analysts are optimistic about Eli Lilly’s stock performance tied to its upcoming product launches and earnings potential.
2026-01-30 17:02:36 Eli Lilly's investment in building a $3.5 billion manufacturing plant in Pennsylvania signifies a push to strengthen domestic production capabilities.
2026-01-30 17:02:36 The expected Medicare coverage of obesity drugs is seen as a significant positive change that could drive sales for Eli Lilly.
2026-01-30 17:02:36 Eli Lilly is actively developing and launching new obesity medications, like orforglipron and retatrutide, indicating strong innovation in the market.
2026-01-30 15:48:53 The investment in a U.S. plant reflects a commitment to domestic manufacturing and could enhance the company's production capabilities.
2026-01-30 15:48:53 Eli Lilly's strategy to build a new plant in the U.S. indicates a focus on improving supply chain efficiency and domestic production capabilities.
2026-01-30 13:49:14 The focus on producing innovative drugs like retatrutide highlights the company's strategic direction towards enhancing its product offerings in the obesity and diabetes markets.
2026-01-30 13:49:14 The $3.5 billion investment in the new manufacturing facility demonstrates Eli Lilly's commitment to increasing production capacity for its growing portfolio of drugs.
2026-01-30 13:49:14 Eli Lilly's announcement of the new plant in Pennsylvania reflects a significant trend in the pharmaceutical industry toward expanding domestic manufacturing capabilities.
2026-01-30 11:49:17 The development of next-generation obesity injections shows promising advancements in the field of weight loss therapeutics.
2026-01-30 11:49:17 Eli Lilly's investment in a new manufacturing plant indicates a strong commitment to the development of new obesity treatments, signaling future growth potential.
2026-01-30 11:49:17 The delay in the FDA decision on Eli Lilly's weight loss pill may negatively impact investor sentiment and stock performance.
2026-01-30 09:35:02 The failure to obtain a heart-failure label extension may impact Mounjaro's market potential and sales growth in the obesity treatment sector.
2026-01-30 09:35:02 Eli Lilly's inability to secure EU approval for Mounjaro indicates significant regulatory hurdles in expanding its therapeutic indications.


About   Contact Us  
Copyright ©2025 TheMarketUnfolds. All rights reserved. Denver, Colorado, USA